US FDA accepts Genentech’s NDA under priority review for giredestrant in ER-positive early-stage breast cancer: South San Francisco, California Wednesday, June 3, 2026, 09:00 Hr ...
Loyalty Juggernaut, creator of GRAVTY®, the world's leading cloud-native, enterprise growth platform, today announced at the Loyalty Summit EMEA the successful go-live of Spenn, Norwegian Reward, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results